☰

cached image

Wafa T. Al-Jamal, PhD

Affiliations: 
2004-2008 The School of Pharmacy University of London, London, England, United Kingdom 
 2012-2013 Institute of Pharmaceutical Science King's College London, London, UK 
 2013-2017 School of Pharmacy University of East Anglia, Norwich, England, United Kingdom 
 2017- School of Pharmacy Queen's University Belfast, Belfast, Northern Ireland, United Kingdom 
Area:
Nanomedicine, Drug Delivery, Liposome
Website:
https://pure.qub.ac.uk/portal/en/persons/wafa-aljamal(d931b6ec-d950-47da-bfb2-d2a6fd7a6aa7).html
Google:
"Wafa Al-Jamal"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Kostas Kostarelos grad student 2004-2008 University of London
Kostas Kostarelos post-doc 2008-2012 UCL

Children

Sign in to add trainee
Matthew Barker grad student 2018- Queen's University Belfast
Na Li grad student 2018- Queen's University Belfast
Raphael Egbu grad student 2014-2015 University of East Anglia
Duuamene Nyimanu grad student 2014-2015 University of East Anglia
Calvin Cheung grad student 2016-2019 Queen's University Belfast
Cédrik-Roland Koffi grad student 2016-2019 Queen's University Belfast
Sara Pereira grad student 2016-2019 Queen's University Belfast
Maja Severic grad student 2016-2019 Queen's University Belfast
Hatem A. F. M. Hassan post-doc 2017- Queen's University Belfast
Guanglong Ma post-doc 2018- Queen's University Belfast
Gladys Amalia Ruiz post-doc 2018- Queen's University Belfast
Chang Yang post-doc 2018- Queen's University Belfast

Collaborators

Sign in to add collaborator
Kuo-Ching Mei collaborator 2010-2012 UCL School of Pharmacy
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yang C, Zhao Q, Yang S, et al. (2022) Intravenous Administration of Scutellarin Nanoparticles Augments the Protective Effect against Cerebral Ischemia-Reperfusion Injury in Rats. Molecular Pharmaceutics
Al-Jamal WT, Kostarelos K. (2022) Mild hyperthermia accelerates doxorubicin clearance from tumour-extravasated temperature-sensitive liposomes. Nanotheranostics. 6: 230-242
Pereira S, Ma G, Na L, et al. (2021) Encapsulation of doxorubicin prodrug in heat-triggered liposomes overcomes off-target activation for advanced prostate cancer therapy. Acta Biomaterialia
Silva VL, Ruiz A, Ali A, et al. (2021) Hypoxia-Targeted Cupric-Tirapazamine Liposomes Potentiate Radiotherapy in Prostate Cancer Spheroids. International Journal of Pharmaceutics. 121018
Ma G, Severic M, Barker M, et al. (2021) Dually Targeted Bioinspired Nanovesicle Delays Advanced Prostate Cancer Tumour Growth In Vivo. Acta Biomaterialia
Ma G, Kostevšek N, Monaco I, et al. (2021) PD1 blockade potentiates the therapeutic efficacy of photothermally-activated and MRI-guided low temperature-sensitive magnetoliposomes. Journal of Controlled Release : Official Journal of the Controlled Release Society
Severic M, Ma G, Pereira S, et al. (2020) Genetically-engineered anti-PSMA exosome mimetics targeting advanced prostate cancer in vitro and in vivo. Journal of Controlled Release : Official Journal of the Controlled Release Society
Cheung CCL, Monaco I, Kostevšek N, et al. (2020) Nanoprecipitation preparation of low temperature-sensitive magnetoliposomes. Colloids and Surfaces. B, Biointerfaces. 111453
Ruiz A, Ma G, Seitsonen J, et al. (2020) Encapsulated doxorubicin crystals influence lysolipid temperature-sensitive liposomes release and therapeutic efficacy in vitro and in vivo. Journal of Controlled Release : Official Journal of the Controlled Release Society
Pereira SGT, Hudoklin S, Kreft ME, et al. (2020) Correction to "Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Toward Prodrug-Nanomedicine Design". Molecular Pharmaceutics
See more...